Over 3 years of surveillance, the program received 454 case reports classified generic ultram as tramadol abuse. Eleven such reports were received by the FDA. In addition there have been 115 reports of adverse events described as drug abuse, dependence, withdrawal or intentional overdose. Forward-looking statements include, but are not necessarily limited to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials and finished products, third parties, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. Business Editors & Health/Medical Writers Able Laboratories, Inc. The drug combines acetaminophen, the main ingredient in Johnson & Johnson's generic ultram tylenol, with tramadol hydrochloride, a compound used in the painkiller Ultram. The submission of this important product is a further establishment of Biovail's FlashDose technology and its application to making medicines more generic ultram acceptable and convenient for patients. Biovail is evaluating options for commercialization of the pain franchise and is currently in discussions with multiple potential partners regarding out-licensing Ralivia ER alone or in conjunction with Biovail's orally disintegrating pain products. Eugene Melnyk, Chairman of the Board and Chief Executive Officer commented, The filing of Ralivia FlashDose is very significant, complementing our filing of Ralivia ER and marking our development of a franchise of pain medications.
And is not affiliated with Eon Labs, Inc.
Business Editors/Health & Medical Writers JERUSALEM--(BW HealthWire)--Jan. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light generic ultram of these important factors. Swallowing difficulty or dysphagia itself is a frequent complication of a number of diseases including stroke, Parkinson's disease and commonly associated with the progression of aging and is a major problem in the care of the elderly. In addition, Biovail has been developing eight flash dose products and four genetic compounds. There is no assurance that the Company will achieve the sales levels that will make its operations profitable or that ANDA filings and approvals will be completed and obtained as anticipated. Safe Harbor generic ultram statement under the U. For example, statements about the Company's operations, capital-raising transactions and financial accounting, the current or expected market size for its products, the success of current or future product offerings, the research and development efforts and the Company's ability to file for and obtain U. Tramadol exposure is likely suppressed in generic ultram addiction communities with access to preferred, more potent or euphoriant opioids than tramadol. Forward-looking statements are merely the Company's current predictions of future events. (OTCBB:ABLA) (BSE:ABRX) today generic ultram announced that the U. The statements are inherently uncertain, and actual results could differ materially from the statements generic ultram made herein.
Tramadol case numbers significantly increased 165% during this generic ultram time. For more information on specific products generic ultram manufactured and distributed by the Eon Labs, please call 1-800-526-0225, write Eon Labs Inc. Generic ultram, 227-15 North Conduit Avenue, Laurelton, New York, 11413, or visit www.